Studies on heterocycle-based pure estrogen antagonists

Area of Science:

• Medicinal Chemistry
• Endocrinology
• Pharmacology

Background:

• Estrogen receptor (ER) modulators are crucial for treating hormone-dependent diseases.
• Nonsteroidal antiestrogens offer therapeutic potential with potentially fewer side effects than steroidal counterparts.

Purpose of the Study:

• To synthesize novel nonsteroidal antiestrogens using 2-phenylindole, benzofuran, and benzothiophene scaffolds.
• To investigate the structure-activity relationships of these compounds, focusing on side chain modifications and their impact on antiestrogenic and antitumor activities.

Main Methods:

• Synthesis of 2-phenylindole, benzofuran, and benzothiophene derivatives with varied side chains.
• Evaluation of estrogenic activity using a luciferase reporter transcription assay and the mouse uterine weight test.
• Assessment of antitumor activity against hormone-sensitive MCF-7 breast cancer cells in vitro.

Main Results:

• Introduction of polar functional groups into the side chain enhanced antiestrogenic potency.
• Amide derivatives exhibited no agonistic activity in vitro or in vivo.
• Sulfur-containing side chains (alkylthio, alkylsulfonyl) on benzothiophenes demonstrated potent antiestrogenic activity (IC50 ~1 nM) and significant antitumor effects.
• 2-Phenylindoles and 2-phenylbenzothiophenes showed comparable potencies, while benzofurans were less active.

Conclusions:

• Novel nonsteroidal antiestrogens with potent antiestrogenic and antitumor activities were developed.
• Sulfur-containing side chains are critical for high potency, particularly in 2-phenylbenzothiophene derivatives.
• The luciferase reporter assay effectively predicts in vivo estrogenic activity, validating its use in drug discovery.